Khora

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Scorpion

This company develops small molecule precision oncology therapies for patients with various cancers.

Ikena Oncology

This clinical-stage biotechnology company develops targeted oncology therapies and small molecule modulators for patients with biomarker-driven cancers and unmet medical needs.

K36 Therapeutics

This biotechnology company develops small molecule inhibitors targeting epigenetic pathways to treat cancers such as multiple myeloma and prostate cancer.

Synnovation Therapeutics

This company develops small molecule precision medicines and targeted therapies to treat cancer patients.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Fore Biotherapeutics

This precision oncology company develops targeted therapies for patients with unaddressed cancer mutations, including a specific BRAF inhibitor for advanced solid tumours.